McDermott Michael's most recent trade in Pfizer Inc. was a trade of 289,196 Stock Appreciation Rights done . Disclosure was reported to the exchange on March 4, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 289,196 | 289,196 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.31 per share. | 27 Feb 2025 | 48,419 | 122,413 (0%) | 0% | 31.3 | 1,515,999 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 48,419 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.06 per share. | 27 Feb 2025 | 45,347 | 75,958 (0%) | 0% | 26.1 | 1,181,743 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 27 Feb 2025 | 1,108 | 121,305 (0%) | 0% | 26.1 | 28,919 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.42 per share. | 26 Feb 2025 | 3,220 | 73,994 (0%) | 0% | 26.4 | 85,072 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2025 | 11,125 | 87,636 (0%) | 0% | 30.2 | 335,641 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 11,125 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.08 per share. | 22 Feb 2025 | 9,925 | 77,214 (0%) | 0% | 26.1 | 258,844 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 22 Feb 2025 | 497 | 87,139 (0%) | 0% | 26.3 | 13,071 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 30,421 | 117,267 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 30,421 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 19,015 | 126,853 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 19,015 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.06 per share. | 16 Feb 2025 | 9,429 | 107,838 (0%) | 0% | 7.1 | 66,522 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 6,583 | 127,931 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 6,583 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.06 per share. | 16 Feb 2025 | 5,505 | 121,348 (0%) | 0% | 7.1 | 38,838 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.87 per share. | 16 Feb 2025 | 1,906 | 126,025 (0%) | 0% | 6.9 | 13,094 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 250,718 | 250,718 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 101,346 | 101,346 | - | - | Restricted Stock Units | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 45,920 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 45,920 | 45,920 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 34,234 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 34,234 | 34,234 | - | - | Stock Appreciation Rights | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 87,751 | 120,978 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 87,751 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.06 per share. | 05 Jul 2024 | 34,132 | 86,846 (0%) | 0% | 6.1 | 206,840 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 125,347 | 125,347 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | McDermott Michael | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 110,756 | 110,756 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2024 | 12,412 | 95,408 (0%) | 0% | 27.3 | 339,344 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 12,412 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | McDermott Michael | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 23 Feb 2024 | 10,031 | 84,518 (0%) | 0% | 27.4 | 274,548 | Common Stock |
Pfizer Inc. | McDermott Michael | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.18 per share. | 23 Feb 2024 | 6,063 | 75,463 (0%) | 0% | 27.2 | 164,792 | Common Stock |
Pfizer Inc. | McDermott Michael | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 2,992 | 81,526 (0%) | 0% | 27.8 | 83,058 | Common Stock |
Pfizer Inc. | McDermott Michael | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 859 | 94,549 (0%) | 0% | 27.8 | 23,846 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 91,264 | 91,264 | - | - | Restricted Stock Units | |
Newell Brands Inc | P. Michael McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 19,015 | 38,732 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | Michael McDermott P. | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 19,015 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 8,539 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael McDermott P. | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 8,539 | 22,190 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | McDermott Michael P. | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 7,114 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | McDermott P. Michael | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 7,114 | 16,088 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | Michael McDermott P. | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.67 per share. | 16 Feb 2024 | 5,505 | 33,227 (0%) | 0% | 7.7 | 42,223 | Common Stock |
Newell Brands Inc | McDermott P. Michael | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.67 per share. | 16 Feb 2024 | 2,473 | 19,717 (0%) | 0% | 7.7 | 18,968 | Common Stock |
Newell Brands Inc | P. Michael McDermott | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.67 per share. | 16 Feb 2024 | 2,437 | 13,651 (0%) | 0% | 7.7 | 18,692 | Common Stock |
Rhinebeck Bancorp Inc | Michael J. McDermott | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.92 per share. | 25 Aug 2023 | 1,174 | 8,500 (0%) | 0% | 6.9 | 8,122 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 87,751 | 87,751 | - | - | Restricted Stock Units | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 14,178 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2023 | 14,178 | 93,099 (0%) | 0% | 22.9 | 324,534 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.44 per share. | 25 Feb 2023 | 6,305 | 83,955 (0%) | 0% | 43.4 | 273,889 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.78 per share. | 25 Feb 2023 | 3,081 | 80,874 (0%) | 0% | 40.8 | 125,643 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.75 per share. | 25 Feb 2023 | 2,839 | 90,260 (0%) | 0% | 41.7 | 118,528 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 45,920 | 45,920 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 39,965 | 39,965 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2023 | 13,307 | 88,957 (0%) | 0% | 30.2 | 401,472 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 13,307 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.70 per share. | 22 Feb 2023 | 8,101 | 78,921 (0%) | 0% | 43.7 | 354,014 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.38 per share. | 22 Feb 2023 | 1,935 | 87,022 (0%) | 0% | 42.4 | 82,005 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 57,046 | 57,046 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 13,045 | 0 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 13,045 | 13,045 (0%) | 0% | 0 | Common Stock | |
Newell Brands Inc | Michael P. McDermott | Segment CEO - Home & Com. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.90 per share. | 17 Feb 2023 | 4,071 | 8,974 (0%) | 0% | 14.9 | 60,658 | Common Stock |
Rhinebeck Bancorp Inc | Michael J. McDermott | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.58 per share. | 25 Aug 2022 | 1,174 | 9,674 (0%) | 0% | 9.6 | 11,247 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.60 per share. | 26 Feb 2022 | 12,340 | 83,530 (0%) | 0% | 25.6 | 315,904 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 12,340 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.64 per share. | 26 Feb 2022 | 5,761 | 75,397 (0%) | 0% | 50.6 | 291,737 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.72 per share. | 26 Feb 2022 | 2,372 | 81,158 (0%) | 0% | 47.7 | 113,192 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.94 per share. | 26 Feb 2022 | 1,384 | 74,013 (0%) | 0% | 46.9 | 64,965 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 34,234 | 34,234 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 30,109 | 30,109 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2022 | 14,952 | 81,518 (0%) | 0% | 27.3 | 408,788 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 14,952 | 0 | - | - | Stock Appreciation Rights | |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. | 23 Feb 2022 | 7,401 | 71,190 (0%) | 0% | 51.3 | 379,523 | Common Stock |
Pfizer Inc. | Michael McDermott | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.87 per share. | 23 Feb 2022 | 2,927 | 78,591 (0%) | 0% | 46.9 | 137,188 | Common Stock |
Newell Brands Inc | Michael P. McDermott | Business Unit CEO - Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 49,376 | 49,376 | - | - | Stock Option (Right to Buy) | |
Newell Brands Inc | Michael P. McDermott | Business Unit CEO - Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 6,583 | 6,583 | - | - | Restricted Stock Units | |
Newell Brands Inc | Michael P. McDermott | Business Unit CEO - Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 64,037 | 64,037 | - | - | Stock Option (Right to Buy) | |
Newell Brands Inc | Michael P. McDermott | Business Unit CEO - Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 8,539 | 8,539 | - | - | Restricted Stock Units | |
Rhinebeck Bancorp Inc | Michael J. McDermott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2020 | 28,000 | 28,000 | - | - | Stock Options | |
Rhinebeck Bancorp Inc | Michael J. McDermott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2020 | 12,000 | 12,000 (0%) | 0% | 0 | Common Stock |